Clinical Trials Browser

OTHER × Paranasal Sinus Neoplasms × camrelizumab × Clear all

NCT05114707 2021-11-10

Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses

Phase 2 Unknown

Paranasal Sinus Neoplasms